Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Enzymotec Announces New DHA-Based Supplement - Happi
Supplier's Corner

Enzymotec Announces New DHA-Based Supplement

Enzymotec has developed a new DHA-delivery system that is capable of improving DHA bio-availability.
Earlier this year Enzymotec had concluded an animal and human study on a proprietary structured derivative of the DHA-phospholipid system, exhibiting a better DHA availability over fish DHA or mixtures of DHA and phospholipids and consequently a superior biological effect, thus supporting past scientific literature and the benefits of using advanced DHA delivery systems.
Enzymotec, a lipid nutrition company, is the developer and producer of CardiaBeat for CVD prevention, SharpPS for cognitive enhancement, and InFat for better calcium and energy absorptions as well as easy digestion for infants. More info: Orly Farkash, orly@enzymotec.com; 972-4-6545112.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters